News Polsky Center Fall 2021 I-Corps Teams Tackle Unmet Medical Needs, Data Transparency, and Other Challenges The Polsky Center’s fall 2021 I-Corps cohort is developing diagnostics, novel therapeutics, innovative devices, new materials, and other technologies across various industries. The Polsky I-Corps program is a 7-week highly-experiential...
News Polsky Center Funds Students Who Are “All In” Scott Kitun holds an all hands on deck discussion about the UChicago Polsky Center. Entrepreneurship is now a top program at UChicago’s Booth School of Business. Associate Vice President for Entrepreneurship...
News Digital Health, Therapeutics Startups Selected for George Shultz Innovation Fund Finals The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has announced the companies selected for the 2022 fall cohort of the George Shultz Innovation Fund. Managed by the...
News Life Sciences, Tech Startups Advance to Fall 2023 George Shultz Innovation Fund Finals Researchers have developed a proprietary machine learning approach, multi-tissue human organoid model, and a targeted drug delivery method – and will be seeking investment at the fall 2023 George Shultz...
News Two UChicago Startups Receive Investment from the George Shultz Innovation Fund The George Shultz Innovation Fund (fall 2023 cycle) has awarded $200,000 to NetMicroscope and $150,000 to CellCipher to further develop their work. Managed by the Polsky Center for Entrepreneurship and...
News Multi-Tissue Organoid Better Predicts Human Response to Drug Treatments: CellCipher CellCipher has developed a new type of organoid model that captures nearly 70 different cell types to enable drug discovery and personalized medicine. In vitro human models, including organoids and...
Technology Antibody Blockade Method To Augment Hemolysis For Treatment Of Sepsis Sepsis is a systemic response to infection and remains a leading cause of death in intensive care units worldwide while our understanding of the pathogenesis of sepsis across most tissues…
